Medical/Pharmaceuticals
Over 250 million people worldwide unaware they have diabetes, according to new research from the International Diabetes Federation (IDF)
New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat, with nearly one in nine adults now living with the condition. BRUSSELS, April 7, 2025 /PRNewswire/ -- Globally, nearly one in nine adults (589 million) are now living with diabetes. Of these, an estimated 252 million...
2025-04-07 17:00
2589
Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution
Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency and care quality, optimizes patient and user experience, and enhances clinical outcomes and operational efficiency. SAN ANTONIO, April 7, 2025 /PRNewswire/ -- Frost & Sullivan recently assessed the AI-enabl...
2025-04-07 10:00
3328
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases
- ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases - Programs will leverage ABL Bio's Grabody-B platform technology to effectivelydeliver molecules across the blood-brain barrier - ABL Bio to receive up to £77 million in upfront and n...
2025-04-07 08:34
4908
George Clinical Rebrands as Emerald Clinical Trials
New name reflects company's growth and vision to help bring certainty and transparency to global clinical trials SINGAPORE, April 7, 2025 /PRNewswire/ -- George Clinical, a leading clinical research organization (CRO) operating worldwide, is pleased to announce it has rebranded to becomeEmerald ...
2025-04-07 08:00
2703
Telix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr.Paul Schaffer to the newly created role of Chief Technology Officer (CTO), effective today. Dr. Schaffer has...
2025-04-07 07:09
3998
Farrer Park Hospital and Alliance Healthcare Group Limited Forge Strategic Partnership to Enhance Patient Care and Promote Sustainable Healthcare Models
SINGAPORE, April 3, 2025 /PRNewswire/ -- Farrer Park Hospital and Alliance Healthcare Group Limited (Alliance) had on27 March 2025 entered into a strategic partnership to drive innovation in healthcare delivery, strengthen collaboration between providers, payers, and physicians, and improve patie...
2025-04-03 17:00
3185
IRBM Expands Functional Genomics Platform to Strengthen Early Drug Discovery
De-Risking Target Validation with Data-Driven Genomic Insights ROME, April 3, 2025 /PRNewswire/ -- IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target identific...
2025-04-03 07:45
4701
LBB Specialties Partners with Kerry Group to Launch Pharmaceutical Lactose to the Life Sciences Market
NORWALK, Conn., April 3, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredient distribution in North America, is pleased to announce a new partnership with Kerry Group, a world leading taste and nutrition partner for the food, beverage, and pharmaceutical mark...
2025-04-03 01:30
2694
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
The National Comprehensive Cancer Network celebrated its 30th anniversary with a series of presentations on cancer care practice changes—in both treatment and administration—plus new research, and other changes for the oncology workforce and the patients they serve. ORLANDO, Fla., April 2, 2025 ...
2025-04-02 21:06
2383
"miraDry Releases the First Ever Sweat Scope Report, Shedding Light on Underarm Sweat and Odor in Menopause"
NEWPORT BEACH, Calif., April 2, 2025 /PRNewswire/ -- Today, miraDry, Inc., in partnership with the International Hyperhidrosis Society (IHhS), announced the results of a landmark study focusing on a rarely discussed aspect of menopause: underarm sweat and odor. The study, titled "Sweat Scope: The...
2025-04-02 21:00
2708
FWD Hong Kong forms partnerships to launch "Talk2Me Peer Supporter Training Certificate Programme" and "JA SparktheDream Wellness Workshop" to promote youth mental health
HONG KONG, April 2, 2025 /PRNewswire/ -- Youth mental health is one of the most widely discussed social issues inHong Kong. This underscores the need for mental health support for youth. In response, FWD Hong Kong ("FWD") has collaborated with two non-profit organisations,KELY Support Group and J...
2025-04-02 19:12
4131
Fosun International 2024 Annual Results Presentation: Aiming for RMB10 Billion in Future Industrial Operation Profit
HONG KONG and SHANGHAI, April 2, 2025 /PRNewswire/ -- On 1 April 2025, Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group") held its 2024 annual results presentation inShanghai. The results presentation was attended b...
2025-04-02 13:51
5010
Human Frontier Science Program: Research Grants Awarded to 104 of the Most Pioneering Scientists from 30 Nations
STRASBOURG, France, April 2, 2025 /PRNewswire/ -- To pioneer new frontiers in
life science research, the Human Frontier Science Program has awarded 104 of
the world's most ingenious scientists from 30 nations with 2025 HFSP Research
Grants and the first round of the new Accelerator Grants.
2025-04-02 08:10
2609
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
MELBOURNE, Australia, April 2, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89 Zr-olaratumab) in patients with advanced, metastatic soft tissue sarcoma...
2025-04-02 03:30
2862
Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a new drug, indicated for suppression of progressio...
2025-03-31 21:35
2975
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist
-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation of small molecule ASC30 demonstrated potentially ...
2025-03-31 19:00
2569
Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women
Sensoril® Ashwagandha is among Kerry's portfolio of solutions tailored to meet
women's unique health needs
SINGAPORE, March 31, 2025 /PRNewswire/ -- Sensoril® ashwagandha
2025-03-31 17:30
3009
Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing
SUZHOU, China, March 31, 2025 /PRNewswire/ -- Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of ne...
2025-03-31 17:01
4285
Reaffirming Leadership: Medit's Strong Presence at IDS 2025
COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, made a significant impact at International Dental (IDS) 2025 by unveiling its latest innovations in intraoral scanning and comprehensive digital workflows. Alongside new ...
2025-03-31 15:00
3001
S Spine Hospital Launches T-Shirt to Raise Awareness About Back Pain
BANGKOK, March 31, 2025 /PRNewswire/ -- S Spine Hospital, a specialist in
spine, has unveiled "THE SPINE T-SHIRT," a health communication initiative
designed to transform how people perceive and understand spinal health issues.
2025-03-31 14:52
1905
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 322 media titles]
2026-02-10 14:00
Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00
Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
[Picked up by 298 media titles]
2026-02-09 10:00
Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 298 media titles]
2026-02-10 13:31Carro unveils quirky generative AI ad campaign highlighting its 'Surprisingly Short' AI-enabled car-selling process
[Picked up by 296 media titles]
2026-02-11 11:00
Most Read
Rockwell Automation Strengthens Industrial Cybersecurity with New Security Operations Center in Singapore
2026-02-09 10:00
8457
AIA RESEARCH REVEALS INGRAINED HEALTH STEREOTYPES ARE HOLDING BACK WELLBEING IN ASIA
2026-02-09 16:08
6755
Aon and KNIAZHA VIENNA INSURANCE GROUP announce new $25M war-risk insurance facility with the U.S. International Development Finance Corporation
2026-02-09 22:42
6541
Agoda Launches Free Global eSIMs for VIP Diamond Members
2026-02-10 14:00
6138
